Segall Bryant & Hamill’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.46M Buy
86,248
+1,517
+2% +$129K 0.09% 272
2026
Q1
$7.59M Sell
84,731
-4,381
-5% -$421K 0.11% 254
2025
Q4
$8.27M Buy
89,112
+4,020
+5% +$438K 0.11% 252
2025
Q3
$10.6M Buy
85,092
+2,092
+3% +$266K 0.14% 221
2025
Q2
$10.9M Buy
83,000
+14,093
+20% +$1.59M 0.15% 215
2025
Q1
$7.22M Buy
+68,907
New +$7.22M 0.11% 261
2013
Q3
Sell
-50,885
Closed -$2.16M 580
2013
Q2
$2.16M Buy
+50,885
New +$2.17M 0.06% 252

Other funds holding ITRI

Segall Bryant & Hamill's ITRI Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Itron (ITRI) stake by 1.8% in Q2 2026, buying an estimated $129K and bringing the position to 86,248 shares worth $7.46M. The position accounts for 0.09% of the portfolio, ranked #272.

Segall Bryant & Hamill first reported a position in ITRI in Q2 2013 and has held it in 7 quarters since. The position peaked at $10.9M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Segall Bryant & Hamill held 86,248 shares of Itron worth $7.46M as of Q2 2026.
  • Segall Bryant & Hamill bought 1,517 Itron shares in Q2 2026, an estimated $129K.
  • Itron made up 0.09% of Segall Bryant & Hamill's portfolio in Q2 2026, its #272 holding.
  • Segall Bryant & Hamill first reported a position in Itron in Q2 2013 and has held it in 7 quarters since.
  • Segall Bryant & Hamill's Itron position peaked at $10.9M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.